palliative care oncology - Nursing Case Study

Pathophysiology

• Tumor progression and metastasis: Cancer cells proliferate uncontrollably, invading surrounding tissues and spreading to distant organs, leading to severe functional impairments and organ failure.

• Immune system evasion: Cancer cells develop mechanisms to evade immune detection, such as downregulating antigen presentation and secreting immunosuppressive factors, which hinder the body's ability to combat tumor growth.

• Key complication: Cachexia, characterized by severe weight loss and muscle wasting, exacerbates patient weakness, reduces treatment tolerance, and significantly impacts quality of life.

Patient Profile

Demographics:

67-year-old male, retired mechanical engineer

History:

• Key past medical history: Stage IV pancreatic cancer, type 2 diabetes mellitus, hypertension, chronic kidney disease stage 3

• Current medications: Morphine sulfate, Metformin, Lisinopril, Ondansetron, Insulin glargine

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and difficulty breathing

• Key symptoms: Persistent nausea, vomiting, jaundice, confusion, extreme fatigue

• Vital signs: Blood pressure 82/57 mmHg, heart rate 122 bpm, respiratory rate 28 breaths per minute, temperature 101.3°F, oxygen saturation 86% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team ordered a series of diagnostic tests to better understand the patient's current condition and tailor the palliative care approach accordingly. Laboratory results revealed significantly elevated liver enzymes, indicative of hepatic involvement, most likely due to metastatic spread of the pancreatic cancer. The bilirubin level was critically high at 9.2 mg/dL, correlating with the patient's pronounced jaundice. Renal function tests showed a further decline, with a serum creatinine of 3.1 mg/dL, suggesting worsening kidney function likely exacerbated by dehydration and ongoing cachexia. Additionally, blood glucose levels were poorly controlled, fluctuating between 250-300 mg/dL, complicating the management of his type 2 diabetes in the context of severe illness.

Imaging studies, including a CT scan of the abdomen and pelvis, confirmed extensive metastatic disease with significant liver involvement and ascites. The scan also indicated possible intestinal obstruction, which could be contributing to the patient's persistent nausea and vomiting. A chest X-ray showed bilateral pleural effusions, which explained the patient's difficulty in breathing and reduced oxygen saturation. The combination of these findings underscores the complexity of the patient's condition, highlighting the need for a multifaceted approach to manage symptoms and improve comfort.

These diagnostic results present a challenging scenario requiring advanced clinical reasoning to prioritize interventions. The focus must shift towards managing pain and discomfort, addressing metabolic imbalances, and supporting respiratory function. This will involve adjusting medication regimens, considering invasive procedures like paracentesis for ascites or pleural effusion drainage, and optimizing nutritional support to mitigate cachexia. As the team synthesizes this information, the goal remains to enhance quality of life while navigating the intricacies of palliative oncology care.

Section 2

Change in Patient Status:

In the days following the implementation of the initial palliative care plan, the patient experienced a notable decline in clinical status. Despite adjustments to his medication regimen, including increased doses of opioid analgesics for pain management and antiemetics for nausea, the patient reported escalating abdominal pain and a sense of fullness. His vital signs revealed a low-grade fever of 100.8°F, a heart rate elevated at 115 bpm, and blood pressure reading of 95/60 mmHg, suggesting a possible infectious process or further hemodynamic instability. Oxygen saturation continued to hover around 88% on room air, necessitating supplemental oxygen to maintain adequate levels.

The patient also exhibited increased confusion and somnolence, raising concerns about hepatic encephalopathy, given his elevated ammonia levels at 85 µmol/L. The healthcare team debated the risks versus benefits of initiating lactulose therapy in light of his fluctuating blood glucose levels and overall nutritional status. In parallel, repeat labs showed further deterioration in renal function, with a serum creatinine now at 3.8 mg/dL and blood urea nitrogen (BUN) at 68 mg/dL, indicating acute kidney injury likely compounded by dehydration and potential nephrotoxic drug effects.

Given these changes, the team faced critical decisions regarding the escalation of care, specifically whether to pursue aggressive management of complications or to focus strictly on comfort measures. The patient's family was engaged in discussions about his goals of care, emphasizing the importance of aligning clinical interventions with the patient's values and preferences. As the team navigated these complex considerations, the emphasis remained on maintaining dignity and quality of life during this challenging phase of the patient's illness trajectory.

Section 3

In light of the patient's declining condition, the healthcare team conducted a comprehensive reassessment, uncovering several new diagnostic findings. A CT scan of the abdomen, performed to investigate the worsening abdominal pain and sense of fullness, revealed significant bowel obstruction due to tumor progression. This finding explained the patient's escalating symptoms and warranted a multidisciplinary discussion about the feasibility and potential impact of surgical intervention versus conservative management.

Further complicating the clinical picture, blood cultures drawn to assess the low-grade fever and hemodynamic instability returned positive for Escherichia coli, indicating a secondary bacterial infection likely stemming from a compromised gastrointestinal tract. This prompted the initiation of broad-spectrum antibiotics; however, the team remained cautious, considering the patient's deteriorating renal function and the potential for exacerbating nephrotoxicity.

The patient's cognitive status continued to decline, with increased confusion and lethargy, raising the suspicion of multifactorial delirium. Contributing factors included hepatic encephalopathy, infection, and potential opioid-induced neurotoxicity. The team weighed the risks of escalating lactulose therapy against the possibility of further destabilizing glucose levels, ultimately deciding to proceed with careful monitoring and a tailored dosing strategy. As they balanced these complex issues, the emphasis remained on reevaluating and aligning with the patient's and family's wishes, ensuring that each decision supported the overarching goal of maximizing comfort and dignity in his remaining time.

Section 4

As the healthcare team continued to manage the complexities of the patient's condition, a new complication emerged. Despite the initiation of broad-spectrum antibiotics, the patient's fever persisted, and his hemodynamic status continued to be unstable, with blood pressure readings consistently low at 85/55 mmHg and a heart rate fluctuating around 110 beats per minute. Laboratory results showed a concerning trend of rising creatinine levels, now at 2.8 mg/dL, indicating worsening renal function. Additionally, his liver function tests revealed elevated bilirubin at 4.5 mg/dL and transaminases, suggestive of advancing hepatic impairment, likely exacerbated by the tumor burden and potential sepsis.

Amid these challenges, the patient's cognitive state further deteriorated. His Glasgow Coma Scale score dropped to 10, reflecting a significant decline in responsiveness, with continued lethargy and episodes of agitation. This cognitive decline was compounded by metabolic derangements, with ammonia levels rising to 85 µmol/L, reinforcing the suspicion of hepatic encephalopathy. The team faced the critical decision of whether to continue adjusting lactulose therapy, given the dual risks of worsening encephalopathy and the potential for precipitating severe diarrhea, which could further strain the patient's already fragile electrolyte balance.

Faced with these evolving complications, the interdisciplinary team engaged in a deep discussion, focusing on the feasibility of additional diagnostic imaging to assess the progression of the bowel obstruction and the potential risks of surgical intervention in such a debilitated patient. The primary goal remained the alleviation of symptoms to optimize the patient's quality of life. Conversations with the family became pivotal, as they considered transitioning to a more palliative-focused approach, emphasizing comfort care measures while respecting the patient's previously expressed wishes. The team prepared to introduce a palliative care consult, striving to align the medical interventions with the patient's values and goals in this complex and delicate phase of his journey.

Section 5

As the healthcare team continued to monitor the patient's condition closely, new diagnostic results emerged, further complicating the clinical picture. A CT scan of the abdomen revealed significant progression of the bowel obstruction, with dilated loops of bowel and signs of ischemia, raising the suspicion of impending bowel necrosis. This finding posed a significant dilemma, as surgical intervention carried high risks due to the patient's precarious hemodynamic status and multi-organ dysfunction. The interventional radiology team was consulted to evaluate the possibility of less invasive decompression techniques, but the likelihood of success remained uncertain given the extent of the obstruction and the patient's overall condition.

Simultaneously, the infectious disease team reviewed the persistence of the patient's fever and worsening renal and hepatic function, considering the potential for a resistant organism or fungal infection contributing to the sepsis picture. Blood cultures remained negative, complicating the decision-making process regarding antimicrobial therapy adjustments. In collaboration with the pharmacy team, the decision was made to initiate empirical antifungal therapy while continuing the broad-spectrum antibiotics, closely monitoring for any signs of improvement or further decline.

In the midst of these developments, the patient's family grappled with the reality of his declining condition. The palliative care team facilitated a family meeting to discuss the recent findings and the limited options available. Emphasizing the need to honor the patient's comfort and dignity, the team recommended focusing on symptom management, including optimizing pain control and addressing agitation with low-dose antipsychotics. The discussion underscored the importance of aligning care with the patient's values, with the family expressing a desire to prioritize comfort measures over aggressive interventions. This shared decision-making approach aimed to ensure that the patient's remaining time was as peaceful and meaningful as possible, marking a pivotal transition in his care journey.